Does UPADACITINIB Cause Decreased appetite? 447 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 447 reports of Decreased appetite have been filed in association with UPADACITINIB (Rinvoq). This represents 0.7% of all adverse event reports for UPADACITINIB.
447
Reports of Decreased appetite with UPADACITINIB
0.7%
of all UPADACITINIB reports
91
Deaths
242
Hospitalizations
How Dangerous Is Decreased appetite From UPADACITINIB?
Of the 447 reports, 91 (20.4%) resulted in death, 242 (54.1%) required hospitalization, and 89 (19.9%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 447 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which UPADACITINIB Alternatives Have Lower Decreased appetite Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL